Showcase of our trial-ready GlucoBeam™

We will exhibit our cutting-edge non-invasive glucose monitor, GlucoBeam at ATTD 2019 

ATTD (Advanced Technologies & Treatment for Diabetes), one of the World’s leading scientific forums for showcasing the latest breakthroughs in diabetes technology, will be held in Berlin later this week. Set to make our first conference appearance as an exhibitor at the prestigious New Technologies Fair, we will unveil the version of GlucoBeam to be used in our upcoming pivotal trial, a key step towards obtaining regulatory approval.

The technology represents the culmination of over 10 years of research and testing to integrate the company’s proprietary critical depth Raman technology into an all-in-one consumer glucose monitoring device for daily home-use. While the hardware is similar to the future commercial version, the software is still being finalized in preparation for GlucoBeam’s market launch.

We are extremely excited about the opportunity to introduce RSP Systems to industry specialists, scientists and key opinion leaders at ATTD and to showcase our trial-ready technology. We are looking forward to making the premium consumer version of GlucoBeam available to the public soon.

Anders Weber, CSO will be giving a talk at the fair and we will be present at Booth 42.


Share on facebook
Share on twitter
Share on linkedin

More news

Ulla-Britt joined our team right after we moved into our new building in mid-February 2018. She comes with a variety of professional …

Non-invasive monitoring of glucose successfully demonstrated in home-use We are happy to announce that our first article, entitled ‘Critical-depth Raman spectroscopy enables …

Meet Sisse who has recently joined our design team as a Project Engineer. Sisse was introduced to RSP during her bachelor studies, …